{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Lyndhurst",
      "state": "NJ",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "81858",
      "recalling_firm": "Amerigen Pharmaceuticals Inc.",
      "address_1": "9 Polito Ave Ste 900",
      "address_2": "",
      "postal_code": "07071-3410",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Product was distributed to 4 wholesalers and 2 retail accounts who may have further distributed the products.",
      "recall_number": "D-0344-2019",
      "product_description": "Temozolomide Capsules, 20 mg, packaged in a a) 5-count (NDC 43975-253-05) and b) 14 count (NDC 43975-253-14) bottles, Rx only, Mfd, by: Stason Pharmaceuticals, Inc., Irvine, CA, Dist. By: Amerigen Pharmaceuticals, Lyndhurst, NJ",
      "product_quantity": "3552 bottles",
      "reason_for_recall": "Failed Dissolution Specifications",
      "recall_initiation_date": "20181220",
      "center_classification_date": "20181226",
      "termination_date": "20191217",
      "report_date": "20190102",
      "code_info": "a) Lot # 18B005 A and b) Lot # 18B005 B, exp 02/2020",
      "more_code_info": ""
    }
  ]
}